BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21999644)

  • 1. Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
    Préau M; Protopopescu C; Raffi F; Rey D; Chêne G; Marcellin F; Perronne C; Ragnaud JM; Leport C; Spire B;
    AIDS Care; 2012; 24(4):434-43. PubMed ID: 21999644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
    Protopopescu C; Raffi F; Brunet-François C; Salmon D; Verdon R; Reboud P; Carrieri MP; Leport C; Spire B; Michel L;
    Antivir Ther; 2012; 17(6):1079-83. PubMed ID: 22544079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment.
    Préau M; Leport C; Salmon-Ceron D; Carrieri P; Portier H; Chene G; Spire B; Choutet P; Raffi F; Morin M
    AIDS Care; 2004 Jul; 16(5):649-61. PubMed ID: 15223534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
    Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
    Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).
    Carrieri MP; Villes V; Raffi F; Protopopescu C; Preau M; Salmon D; Taieb A; Lang JM; Verdon R; Chene G; Spire B;
    Int J Drug Policy; 2007 Aug; 18(4):288-95. PubMed ID: 17689377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
    Azmeraw D; Wasie B
    Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of quality of care in HIV/AIDS programmes among patients in a tertiary health care facility in Anambra State.
    Nwabueze SA; Adogu PO; Ilika AL; Asuzu MC; Adinma ED
    Niger J Med; 2011; 20(1):144-50. PubMed ID: 21970277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
    AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon.
    Boyer S; Protopopescu C; Marcellin F; Carrieri MP; Koulla-Shiro S; Moatti JP; Spire B;
    Health Policy Plan; 2012 Jul; 27(4):301-15. PubMed ID: 21690123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
    Protopopescu C; Raffi F; Spire B; Hardel L; Michelet C; Cheneau C; Le Moing V; Leport C; Carrieri MP;
    Antivir Ther; 2015; 20(7):763-72. PubMed ID: 25859625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.
    Risa KJ; Nepon L; Justis JC; Panwalker A; Berman SM; Cinti S; Wagener MM; Singh N
    Int J STD AIDS; 2002 Oct; 13(10):706-13. PubMed ID: 12396542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health related quality of life among both current and former injection drug users who are HIV-infected.
    Préau M; Protopopescu C; Spire B; Sobel A; Dellamonica P; Moatti JP; Carrieri MP;
    Drug Alcohol Depend; 2007 Jan; 86(2-3):175-82. PubMed ID: 16930864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)].
    Préau M; Bonnet A; Bouhnik AD; Fernandez L; Obadia Y; Spire B;
    Encephale; 2008 Sep; 34(4):385-93. PubMed ID: 18922241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries.
    Etienne M; Hossain M; Redfield R; Stafford K; Amoroso A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):98-103. PubMed ID: 20207981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
    Luszczynska A; Sarkar Y; Knoll N
    Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.